(Q44473168)

English

Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) pro

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) pro (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

0 references

ejection fraction

1 reference

based on heuristic

inferred from title

4

object named as

K Swedberg

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

J McMurray

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

J Ostergren

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

M Pfeffer

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

C Granger

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

S Yusuf

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

P Held

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

E Michelson

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

B Olofsson

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

CHARM committees and investigators

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

261-270

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Heart failure associated with preserved systolic function: a common and costly clinical entity

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Changes in notions about heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Classification of heart failure in population based research: an assessment of six heart failure scores

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular Dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Heart failure: we need more trials in typical patients

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900052-7

21 January 2018

Identifiers

10.1016/S1388-9842(03)00052-7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44473168&oldid=1866519825"